Two years ago, Christina Ciaramitaro and a dozen other students entered UMass Lowell as the first freshmen to major in pharmaceutical sciences marketing and management. The major combines biomedical ...

The fields of pharmacology and pharmaceutical sciences converge to advance our understanding of how drugs interact with biological systems and how these agents can be engineered for optimal ...

Donald E. Mager has been appointed chair of the Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, effective July 11. Mager, an internationally recognized ...

If you are interested in combining chemistry, biology, mathematics and computer techniques with pharmacology, physiology and biochemistry, to work on the development of treatments to prevent disease ...

Prepare for a variety of careers in the pharmaceutical industry and adjacent settings with a unique program designed to reflect the interdisciplinary environment of this industry. The Department of ...

In our highly collaborative environment, you’ll excel with the support of passionate faculty, staff and classmates across not only the School of Medicine, but also our law, engineering and management ...

Graduate school isn’t a prerequisite for a career in the pharmaceutical industry. VCU will be the first public university in Virginia to offer the BSPS degree when it begins enrolling students in the ...

Chemists have developed a method to furnish a range of molecules with a trifluoromethyl group attached to a sulfur, nitrogen or oxygen atom. Their procedure avoids the use of PFAS reagents. It thus ...

Purdue has just announced a partnership with two Indian universities in the state of Andhra Pradesh -- Andhra University and Sri Venkateswara University -- to collaborate on capacity-building ...

Article ‘Count’ and ‘Share’ for Lanzhou Institute of Husbandry and Pharmaceutical Sciences (LIHPS), CAAS based on listed parameters only. According to the parameters selected above, there are no ...

Mergers and acquisitions have had a “devastating” effect on research and development efforts at drug companies over the next decade, according to John L. LaMattina, who ran Pfizer’s R&D laboratories ...

Scientists comment on Merck (known as MSD in Europe) withdrawing from its planned £1bn London research centre. “This news is a real blow to the UK’s life sciences ambition. No one wants to hear that ...